These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27843131)

  • 21. Caudal type homeobox 2 expression induced by leukocytapheresis might be associated with mucosal healing in ulcerative colitis.
    Tsuchiya K; Hayashi R; Fukushima K; Hibiya S; Horita N; Negi M; Itoh E; Akashi T; Eishi Y; Motoya S; Takeuchi Y; Kunisaki R; Fukunaga K; Nakamura S; Yoshimura N; Takazoe M; Iizuka B; Suzuki Y; Nagahori M; Watanabe M
    J Gastroenterol Hepatol; 2017 May; 32(5):1032-1039. PubMed ID: 27862316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
    Ungar B; Kopylov U; Engel T; Yavzori M; Fudim E; Picard O; Lang A; Williet N; Paul S; Chowers Y; Bar-Gil Shitrit A; Eliakim R; Ben-Horin S; Roblin X
    Aliment Pharmacol Ther; 2017 Jan; 45(2):276-282. PubMed ID: 27862102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients' Satisfaction and Cost Analysis. A Cohort Study in IBD Patients.
    Mazzuoli S; Tricarico D; Demma F; Furneri G; Guglielmi FW
    PLoS One; 2016; 11(11):e0166443. PubMed ID: 27851772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-α-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn's disease: systematic reviews and economic modelling.
    Freeman K; Connock M; Auguste P; Taylor-Phillips S; Mistry H; Shyangdan D; Court R; Arasaradnam R; Sutcliffe P; Clarke A
    Health Technol Assess; 2016 Nov; 20(83):1-288. PubMed ID: 27845027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?
    Rodríguez-Lago I; Benítez JM; Sempere L; Sáez-González E; Barreiro-de Acosta M; de Zárate JO; Cabriada JL
    J Clin Apher; 2019 Dec; 34(6):680-685. PubMed ID: 31518013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Adsorptive Granulocyte and Monocyte Apheresis in Elderly and Pregnant Patients With Ulcerative Colitis.
    Yanagisawa K; Murakami M; Kondo Y; Oguma S; Kobayashi S; Miyasaka H; Shinohara T; Tomori A; Nakano Y; Furuhata S; Ikezoe M
    Ther Apher Dial; 2019 Jun; 23(3):217-223. PubMed ID: 31025815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis.
    Dignass A; Akbar A; Baumgart DC; Bommelaer G; Bouguen G; Cadiot G; Gillessen A; Grimaud JC; Hart A; Hoque S; Makins R; Michiels C; Moreau J; Premchand P; Ramlow W; Schanz S; Subramanian S; von Tirpitz C; Bonaz B
    Scand J Gastroenterol; 2018 Apr; 53(4):442-448. PubMed ID: 29513111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.
    Magro F; Gionchetti P; Eliakim R; Ardizzone S; Armuzzi A; Barreiro-de Acosta M; Burisch J; Gecse KB; Hart AL; Hindryckx P; Langner C; Limdi JK; Pellino G; Zagórowicz E; Raine T; Harbord M; Rieder F;
    J Crohns Colitis; 2017 Jun; 11(6):649-670. PubMed ID: 28158501
    [No Abstract]   [Full Text] [Related]  

  • 29. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management.
    Harbord M; Eliakim R; Bettenworth D; Karmiris K; Katsanos K; Kopylov U; Kucharzik T; Molnár T; Raine T; Sebastian S; de Sousa HT; Dignass A; Carbonnel F;
    J Crohns Colitis; 2017 Jul; 11(7):769-784. PubMed ID: 28513805
    [No Abstract]   [Full Text] [Related]  

  • 30. The Association Between CMV Viremia or Endoscopic Features and Histopathological Characteristics of CMV Colitis in Patients with Underlying Ulcerative Colitis.
    Yang H; Zhou W; Lv H; Wu D; Feng Y; Shu H; Jin M; Hu L; Wang Q; Wu D; Chen J; Qian J
    Inflamm Bowel Dis; 2017 May; 23(5):814-821. PubMed ID: 28426459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of the therapeutic management of ulcerative colitis.
    Aslam N; Lo SW; Sikafi R; Barnes T; Segal J; Smith PJ; Limdi JK
    Therap Adv Gastroenterol; 2022; 15():17562848221138160. PubMed ID: 36478780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors of Colorectal Stricture Associated with Developing High-Grade Dysplasia or Cancer in Ulcerative Colitis: A Multicenter Long-term Follow-up Study.
    Xu W; Ding W; Gu Y; Cui L; Zhong J; Du P
    Gut Liver; 2020 Sep; 14(5):601-610. PubMed ID: 31816674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Inflammatory Bowel Disease: A Comprehensive Review.
    Cai Z; Wang S; Li J
    Front Med (Lausanne); 2021; 8():765474. PubMed ID: 34988090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocytapheresis in patients with inflammatory bowel diseases.
    Woźniak M; Kurnatowska I; Małecka-Panas E; Talar-Wojnarowska R
    Prz Gastroenterol; 2021; 6(2):99-105. PubMed ID: 34276835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future.
    Chen XL; Mao JW; Wang YD
    World J Gastrointest Pathophysiol; 2020 May; 11(3):43-56. PubMed ID: 32435521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of adsorptive granulomonocytapheresis in Chinese patients with ulcerative colitis: A retrospective analysis of 50 cases with focus on factors impacting clinical efficacy.
    Li N; Mao J; Tang H; Zhu L; Tan X; Bi J; Wu H; Chen X; Wang Y
    J Clin Apher; 2020 Aug; 35(4):271-280. PubMed ID: 32378240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adsorptive Granulocyte and Monocyte Apheresis Is Effective in Ulcerative Colitis Patients Both with and without Concomitant Prednisolone.
    Matsuda K; Ohno K; Okada Y; Yagi T; Tsukamoto M; Fukushima Y; Horiuchi A; Shimada R; Ozawa T; Hayama T; Tsuchiya T; Tamura J; Iinuma H; Nozawa K; Aoyagi H; Isono A; Abe K; Kodashima S; Yamamoto T; Kawasaki Y; Tamura Y; Sasajima Y; Kondo F; Hashiguchi Y
    Inflamm Intest Dis; 2020 Feb; 5(1):36-41. PubMed ID: 32232053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Adsorptive Granulocyte and Monocyte Apheresis Effective as an Alternative Treatment Option in Patients with Ulcerative Colitis?
    Jeon SR
    Gut Liver; 2017 Mar; 11(2):171-172. PubMed ID: 28274106
    [No Abstract]   [Full Text] [Related]  

  • 39. Adsorptive Granulocyte and Monocyte Apheresis in the Treatment of Ulcerative Colitis: The First Multicenter Study in China.
    Lai YM; Yao WY; He Y; Jiang X; Gu YB; Chen MH; Liu YL; Yuan YZ; Qian JM
    Gut Liver; 2017 Mar; 11(2):216-225. PubMed ID: 27843131
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.